Drug profile · INN
poractant alfa
CUROSURF
poractant alfa (CUROSURF) is a surfactant agent. Route of administration: intratracheal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — poractant alfa
- US status
- approved
- Class
- —
- Route
- INTRATRACHEAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
poractant alfa (CUROSURF) is a surfactant agent. Route of administration: intratracheal. Current US regulatory status: approved.
Key facts
INN poractant alfa
Brand CUROSURF
Mechanism Surfactant agent
Route INTRATRACHEAL
Formulation SUSPENSION
Mechanism of action
Surfactant agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is poractant alfa?
poractant alfa (CUROSURF) is a surfactant agent. Route of administration: intratracheal. Current US regulatory status: approved.
What is the brand name for poractant alfa?
CUROSURF is a marketed brand name for poractant alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of poractant alfa?
poractant alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.